Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep123 | Steroids, development and paediatric endocrinology | ECE2015

Is there a link between lipid profile and thyroid function modification during somatropinum treatment for GH deficiency in children?

Stejereanu Lavinia , Cima Luminita , Albu Alice , Barbu Carmen , Fica Simona

Background: Previous studies suggested that treatment with somatropinum in children with GH deficiency (GHD) may alter lipid profile and pituitary–thyroid axis function. However, results are divergent and data regarding a possible association between changes of thyroid function and of circulating lipids are scarce. The aim of this study was to report the changes of the lipid profile in children with GHD treated with somatropinum and the relationship between thyroid functi...

ea0037ep197 | Reproduction, endocrine disruptors and signalling | ECE2015

The connection between serum prolactin, TSH, and insulin resistance in polycystic ovary syndrome patients

Albu Alice , Radian Serban , Florea Suzana , Fica Simona

Introduction: Both TSH and prolactin serum levels within normal range were previously reported to be associated with metabolic parameters.Aim: To analyse the connections between serum levels of prolactin, TSH, and insulin resistance in polycystic ovary syndrome patients.Material and methods: 322 PCOS patients (mean age 24.3±5.16 years and mean BMI 28±7.57 kg/m2) with normal serum prolactin and without thyroid d...

ea0037ep431 | Diabetes (complications & therapy) | ECE2015

Microangiopathic complications in latent autoimmune diabetes in adults: relationship with thyroid autoimmunity

Reghina Aura , Sava Elisabeta , Florea Suzana , Fica Simona

Background: Patients with latent autoimmune diabetes in adults (LADA) are a clinically, immunologically, genetically heterogeneous group and the presence of thyroid autoimmunity (TA) appears to contribute to his heterogeneity.The aim was to evaluate the impact of TA on microangiopathic complications in LADA patients.Materials and method: LADA has been defined by the onset of diabetes at ages above 30 years, the lack of need for ins...

ea0037ep652 | Pituitary: basic and neuroendocrinology | ECE2015

IGF1 deficiency in newly diagnosed Graves' disease patients

Martin Sorina , Betivoiu Minodora , Florea Suzana , Fica Simona

Introduction: Thyroid hormones influence GH/IGF1 axis, but previous studies reported discrepant results regarding serum IGF1 levels in hyperthyroidism. We have therefore investigated, at diagnosis, the relationship between serum IGF1 levels/IGF1 z scores and clinical and biological characteristics of Graves’ disease (GD) patients. We also compared IGF1 levels/IGF1 z scores, at diagnosis, between GD and autonomous hyperthyroidism patients.<p class="ab...

ea0037ep1252 | Clinical Cases–Thyroid/Other | ECE2015

Euthyroid Graves' ophthalmopathy in a patient with long-term amiodarone treatment

Betivoiu Minodora , Martin Sorina , Nila Alexandra , Fica Simona

Introduction: Ophthalmopathy, the most common extrathyroidal manifestation of Graves’ disease, occurs in 5% of cases in the absence of hyperthyroidism. Amiodarone, an iodine-rich antiarrhythmic drug, influences thyroid function, causing thyrotoxicosis or hypothyroidism, but its effect on thyroid autoimmunity is still a matter of debate.Case report: We report the case of a 58-year-old woman, suffering from non-sustained ventricular tachycardia, treat...

ea0035p3 | Adrenal cortex | ECE2014

Cardiovascular risk in Cushing's syndrome vs obesity

Martin Sorina , Ionita Andreea , Sirbu Anca , Florea Suzana , Fica Simona

Introduction: Cushing’s syndrome (CS) is associated with central obesity, hypertension, insulin resistance, dyslipidemia, prothrombotic state, manifestations which form a metabolic syndrome. Accelerated vascular senescence, due to metabolic and vascular changes, increases, in CS, the cardiovascular risk and the mortality rates compared to age- and gender-matched population. On the other hand, obesity itself is associated with numerous comorbidities, including hypertension...

ea0070aep982 | Thyroid | ECE2020

Exophtalmos in a hyperthyroid patient – it’s not always Graves ophthalmopathy

Martin Sorina , Mustata Theodor , Predescu Andrada , Fica Simona

Background: Hyperthyroidismcan be associated withorbitopathy that manifests as exophtalmos due to orbital tissue inflammation. Usually the diagnosis is straight forward when an autoimmune thyroid disorder is present, but conditions mimicking Graves orbitopathy can pose a diagnostic challenge.Case report: We report the case of a 51 year old caucasian woman who was referred to our clinic with asymmetrical exophtalmos in november 2019. The patient stated th...

ea0070ep22 | Adrenal and Cardiovascular Endocrinology | ECE2020

A case of hypokalemic paralysis in a young hypertensive man

Cristina Pascu Raluca , Maria Popa Miruna , Sirbu Anca , Fica Simona

Background: Hypokalemia can be caused by decreased intake of potassium or by excessive loss of potassium in the urine or through the gastrointestinal tract. Severe and life-threatening hypokalemia is defined by levels below 2.5 mEq/l and can be associated with muscle weakness, cramping, headaches, palpitations, polydipsia and polyuria. Periodic paralysis is a very rare presentation in Caucasians.Case presentation: A 50-year-old Caucasian man, without pre...

ea0070ep85 | Bone and Calcium | ECE2020

Improvement of bone mass density in a pediatric patient with chronic kidney disease and growth failure

Brindusa Plesuvu Iolanda , Gabriela Barbu Carmen , Fica Simona

Introduction: Multiple factors have been incriminated in growth retardation in patients with chronic kidney disease (CKD), such as metabolic acidosis, anemia, vitamin D deficiency with secondary hyperparathyroidism, under-nutrition, renal bone disease. The disease compromises vertical growth with up to one-third children having severe growth delay (below the third percentile for height). Optimal care and nutritional therapy alone, can’t help the children with CKD reach t...

ea0022p207 | Clinical case reports and clinical practice | ECE2010

Childhood nephrogenic diabetes insipidus revealed by urinary megabladder in two adult male brothers

Barbu Carmen , Ionita Dariana , Minea Liudmila , Fica Simona

We present the history of two brothers, 19 and respectively 21 years old who were admitted in our department for reevaluation in the context of renal complications. From their medical history we keep in mind that central DI was diagnosed 15 years ago and desmopresin treatment was indicated. Meanwhile, patients received desmopresin unsteady for very short periods of time (less than 2 years) due to poor adherence and obvious inefficiency of the treatment. They claim medical care...